Victrex (NASDAQ:VTXPF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. The brokerage currently has a $30.00 target price on the stock.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

Victrex (NASDAQ VTXPF) traded up 0.000% during trading on Thursday, reaching $30.091. The firm’s 50 day moving average price is $26.88 and its 200-day moving average price is $26.88. The company has a market capitalization of $2.57 billion and a price-to-earnings ratio of 23.958. Victrex has a 52-week low of $20.00 and a 52-week high of $30.20.

ILLEGAL ACTIVITY WARNING: This article was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.americanbankingnews.com/2017/09/07/victrex-vtxpf-stock-rating-upgraded-by-zacks-investment-research.html.

Get a free copy of the Zacks research report on Victrex (VTXPF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.